David Avarbock
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Infectious Diseases top 2%
- Tuberculosis Research and Epidemiology
Papers in
-
- Tuberculosis Research and Epidemiology 6
- Antimicrobial Resistance in Staphylococcus 1
-
- RNA and protein synthesis mechanisms 3
- Cancer therapeutics and mechanisms 2
- Phenothiazines and Benzothiazines Synthesis and Activities 1
- Co-authors
- Harvey Rubin (8 shared papers)Valerie Mizrahi (3 shared papers)Clifton E. Barry (2 shared papers)Andrew Avarbock (3 shared papers)Todd P. Primm (1 shared paper)Susan J. Andersen (1 shared paper)Edward A. Weinstein (2 shared papers)Zhimei Wang (2 shared papers)
- Journals
- Journal of Bacteriology (3 papers)Biochemistry (2 papers)Proceedings of the National Academy of Sciences (2 papers)Gene (1 paper)
- Partner nations
- United StatesSouth Africa
In The Last Decade
David Avarbock
8 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 66
- Molecular Medicine 246
- Infectious Diseases 686
- Epidemiology 529
- Endocrinology 57
- Molecular Biology 675
Countries citing papers authored by David Avarbock
This map shows the geographic impact of David Avarbock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Avarbock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Avarbock more than expected).
Fields of papers citing papers by David Avarbock
This network shows the impact of papers produced by David Avarbock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Avarbock. The network helps show where David Avarbock may publish in the future.
Co-authors
The 25 scholars most cited alongside David Avarbock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 276 | |
| 2 | 2000 | 269 | |
| 3 | 2005 | 219 | |
| 4 | 2001 | 123 | |
| 5 | 1999 | 89 | |
| 6 | 2000 | 88 | |
| 7 | 2005 | 80 | |
| 8 | 1997 | 43 |
About David Avarbock
David Avarbock is a scholar working on Infectious Diseases, Molecular Biology, Genetics, Epidemiology and Surgery, having authored 8 papers that have together received 1.2k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (6 papers), Bacterial Genetics and Biotechnology (4 papers), RNA and protein synthesis mechanisms (3 papers), Cancer therapeutics and mechanisms (2 papers), Mycobacterium research and diagnosis (2 papers), Phenothiazines and Benzothiazines Synthesis and Activities (1 paper), Amino Acid Enzymes and Metabolism (1 paper) and Antimicrobial Resistance in Staphylococcus (1 paper). The work is most often cited by research in Molecular Medicine (246 citations), Infectious Diseases (686 citations), Epidemiology (529 citations), Endocrinology (57 citations) and Molecular Biology (675 citations). David Avarbock has collaborated with scholars based in United States and South Africa. Frequent co-authors include Harvey Rubin, Valerie Mizrahi, Clifton E. Barry, Andrew Avarbock, Todd P. Primm, Susan J. Andersen, Edward A. Weinstein, Zhimei Wang, Helena I. Boshoff and Gilla Kaplan. Their work appears in journals such as Journal of Bacteriology, Biochemistry, Proceedings of the National Academy of Sciences and Gene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.